RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference171 articles.
1. RNAi therapies: drugging the undruggable;Wu,2014
2. RNA-based therapeutics – current progress and future prospects;Burnett;Chem Biol,2012
3. Oligonucleotide delivery to the lung: waiting to inhale;Kjems;Mol Ther Nucleic Acids,2012
4. Therapeutic oligonucleotides;Goodchild;Methods Mol Biol,2011
5. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14;Lee;Cell,1993
Cited by 123 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments;Journal of Medicinal Chemistry;2023-12-20
2. MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2–GPX2 Molecular Axis in Head–Neck Cancer;Cells;2023-12-17
3. Advances in targeted therapy for pancreatic cancer;Biomedicine & Pharmacotherapy;2023-12
4. Stimuli‐Responsive Nanotechnology for RNA Delivery;Advanced Science;2023-11
5. Lipid nanoparticles for siRNA delivery in cancer treatment;Journal of Controlled Release;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3